Veltassa 8.4 g powder for suspension post-marketing surveillance study

Veltassa 8.4 g powder for suspension post-marketing surveillance study - Veltassa post-marketingnsurveillance study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2031250353

Enrollment

450

Registered

2025-09-10

Start date

2026-07-22

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperkalemia potassium

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients using Veltassa powder for suspension

Exclusion criteria

Exclusion criteria: Contract violation cases or Registration violetion cases

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
efficacy	—

Contacts

Public ContactKatsunori Itou

Zeria Pharmaceutical Co.,Ltd.

katsunori-itou@zeria.co.jp+81-3-3663-2362

Outcome results